Drug Shortage Report for MYLAN-VERAPAMIL SR

Last updated on 2020-06-17 History
Report ID 30729
Drug Identification Number 02450496
Brand name MYLAN-VERAPAMIL SR
Common or Proper name VERAPAMIL SR
Company Name MYLAN PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) VERAPAMIL HYDROCHLORIDE
Strength(s) 240MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL
Packaging size 100BT, 500BT
ATC code C08DA
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2018-10-15
Actual start date 2018-10-15
Estimated end date 2020-06-16
Actual end date 2020-06-16
Shortage status Resolved
Updated date 2020-06-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v100 2020-06-17 French Compare
v99 2020-06-17 English Compare
v98 2020-06-17 French Compare
v97 2020-06-17 English Compare
v96 2020-06-10 French Compare
v95 2020-06-10 English Compare
v94 2020-06-03 French Compare
v93 2020-06-03 English Compare
v92 2020-05-26 French Compare
v91 2020-05-26 English Compare
v90 2020-05-20 French Compare
v89 2020-05-20 English Compare
v88 2020-04-29 French Compare
v87 2020-04-29 English Compare
v86 2019-06-18 French Compare
v85 2019-06-18 English Compare
v84 2019-06-18 French Compare
v83 2019-06-18 English Compare
v82 2019-06-04 French Compare
v81 2019-06-04 English Compare

Showing 1 to 20 of 100